At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Deep Brain Stimulation (DBS) (device)
- How long the study runs
- Study runs about 177 months (dates as stated)
- About the drug or intervention
- Deep Brain Stimulation (DBS) — device: Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their dystonia symptoms will be offered participation in this registry.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 7 Years and over
- Who
- All
- Number of participants
- 300
- Started
- 2016-03-07
- Last checked
- 2026-09
Plain English Summary
What is this study?
- • Testing a new treatment for dystonia
- • Clinical study - 300 participants
- • To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia
Who can take part?
- • Ages 7 Years and over
- • Diagnosed with dystonia
Where?
- • Bristol - Southmead Hospital Bristol
- • Glasgow - Queen Elizabeth University Hospital
- • London - Charing Cross Hospital
- • Newcastle upon Tyne - Royal Victoria Infirmary
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
More detail
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia. Subjects' improvement in disease symptoms and overall Quality of life will be assessed.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 7 Years and over
- Who can join: All genders
Treatment history
Treatments you must have had:
- ✓ in patients who are younger than 18 years at the time of consent
What the study is looking for
- ✓Inclusion Criteria (IC):
- ✓IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia.
- ✓IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the...
- ✓Exclusion Criteria (EC):
- ✓EC1. Meets any safety concern in the Vercise System locally applicable Directions for Use.
See the full criteria
Where Is This Study? (4 UK sites)
Southmead Hospital Bristol
Bristol, United Kingdom
Queen Elizabeth University Hospital
Glasgow, United Kingdom
Charing Cross Hospital
London, United Kingdom
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
How to Get in Touch
Stephanie Delvaux
Sponsor contactCONTACT
Diane Keesey
Sponsor contactCONTACT